In a model of Parkinson’s disease, a small-molecule modulator of σ2R/TMEM97 effectively reduces α-synuclein oligomer toxicity through regulating intracellular lipid vesicle trafficking, autophagy, and cholesterol metabolism [67]. This evidence concerns the gene TMEM97 and Parkinson disease.